With less than one day of O positive left, the Red Cross limits hospital distributions after donations hit a four-year summer low driven by heat and...
The Red Cross's second-ever blood crisis follows 2022 reforms that fixed hospital scheduling but never reached the aging donor pool now driving a four-year.
An FDA panel recommended six peptides, including BPC-157, for pharmacy use, lifting Hims stock 13% even as pricing and enforcement gaps suggest the gray market.
Major Pharmaceuticals recalled 12 subpotent levothyroxine lots and calls the health risk low, but the notice reached retailers, not the patients who take it daily.